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Abstract
Background: Detection of risk factors for an air embolism in the left atrium, left ventricle, or systemic circulation
(systemic air embolism, SAE) during a percutaneous core needle biopsy (PCNB) of the thorax.
Methods: In a retrospective observational study, all PCNBs of the thorax in 610 patients between 2007 and 2009
were analyzed. The SmartStep™ technique (General Electric) was used for the biopsy, with which the examiner can
prepare a batch of three 1.25-mm or 2.5-mm collimated slices within a second using a foot switch in the CT room
to check the needle position. The image data thus generated and the control CT scans that followed were
examined retrospectively for the presence of intravascular air. Intravascular air was defined as two or more adjacent
voxels with absorption values of < -200 HU in the left atrium, left ventricle, aorta, or arteries during or after the
procedure. The univariate statistical analysis of categorical variables was made using 2 by 2 tables and the Fisher
test. The groups were compared using the Mann-Whitney test. Finally, a multivariate logistic regression analysis was
used to identify independent risk factors for the occurrence of an SAE.
Results: The radiological incidence of an SAE during a PCNB was 3.8% (23/610 patients), whereas the clinically
apparent incidence was 0.49%. Two patients developed clinical symptoms consisting of transient hemiplegia or
transient amaurosis; one died due to a fatal SAE of the coronary arteries. The mortality was thus 0.16%. The depth
of the needle in the lesion (Wald: 6.859), endotracheal anesthesia (Wald: 5.721), location of the lesion above the
level of the left atrium (Wald: 5.159), and prone position of the patients (Wald: 4.317) were independent risk factors
for the incidence of an SAE (p < 0.05 each). Using explorative criteria, the acute angle of the needle to the tumor
surface, and the transition of ventilated lung were independent factors. The frequency of biopsies, needle
penetration depth, and tumor location near the diaphragm or in the lower lobe also played a subordinate role, not
however, the needle penetration depth through the lung.
Conclusion: If possible, the PCNB should be performed under local anesthesia. We recommend avoiding
endotracheal anesthesia and prone position. Whenever possible, patients should be positioned on the back in such
a way that the tumor is lower than the left atrium. The tip of the needle should be within the tumor during the
biopsy procedure.
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Background
The occurrence of an air embolism in the left atrium,
left ventricle, or systemic circulation during a percuta-
neous core needle biopsy of the lung (PCNB) [1] with a
subsequent systemic air embolism (SAE), with
incidences between 0.01% and 0.21%, is a rare, but
potentially fatal occurrence [2-8]. The cause of death is
cardiac or cerebral infarction [9,10,]. Aside from other
factors such as accidental intravascular injection and
paradox embolism due to a patent foramen ovale [12],
three mechanisms in particular are responsible during
PCNB: placing the tip of the needle in a pulmonary vein
causing air to be aspirated [11,], the formation of a
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with air passing into the pulmonary vein if the alveolar or
bronchial pressure is high or the venous pressure too low
[15], and passage of air via the pulmonary capillary bed
from the pulmonary artery into the pulmonary venous
system [16], e.g. after pulmonary-arterial injection. Risk
factors can be biopsy of cystic or cavitary lesions includ-
ing vasculitic granulomas, coughing during the biopsy,
and positive pressure ventilation [17]. However, there is
no evidence for any of these factors beyond anecdotal
case study, the lowest level according to GRADE [18] or
the US Preventive Services Task Force classification.
Based on the hypothesis that air embolisms are more fre-
quent than previously assumed [17], in analogy with
other centers [17], systematic control CT scans of the
entire thorax after PCNBs were introduced at our center
in 2007, as has been recommended as standard proce-
dure for this reason for a few months [19]. It was thus
possible for the first time to determine the frequency of
air embolisms and to search for risk factors.
Methods
Patients
Between March 2007 and September 2009, PCNBs were
performed at our institution on a total of 610 patients,
who were all included in the retrospective study. There
were 252 women and 358 men with an average age of
61.7 ± 13.4 years (mean: 63.7; range: 6-87 years). The
patients also included children who were all biopsied
under endotracheal anesthesia. The study was approved
by the local ethics committee.
Biopsied lesions
Of the 610 biopsied lesions, 553 were lesions not in contact
with the pleura or pleural-based lesions, while the remain-
ing lesions were located in the mediastinum. Prior to the
biopsy, a bronchial tumor or primary tumor of the lung
was suspected in 392 cases (64.3%), metastasis of another
malignancy in 108 cases (17.7%), sarcoidosis in 16 cases
(2.6%), an infiltrate of unknown origin in 24 cases (3.9%),
mycosis in 18 cases (3%), vasculitis in 6 cases (1%), and
another disease in 46 cases (7.5%). General anesthesia was
usually used to biopsy lesions that were located in the
immediate vicinity of the heart, were smaller than 0.8 cm,
were located far caudal in the middle lobe or in the lingual,
or were allocated to lymph node stations 10-14 in order to
avoid major complications from bleeding. Children were
also biopsied under general anesthesia. Some patients
required artificial ventilation at the time of the biopsy and
were already intubated when they came for PCNB.
Procedure used to prepare for the biopsies
The patients were informed on the day before the exam-
ination and gave their written consent. Antiplatelet or
anticoagulation drugs such as acetylsalicylic acid, clopi-
dogrel, or phenprocoumon were discontinued at least 10
days prior to the biopsy and generally replaced by low
molecular weight heparin. The preconditions for the
PCNB were blood count, coagulation, and lung function
test. Thrombocytopenic patients were administered pla-
telet concentrates before the biopsy until the platelet
count reached at least 60,000/ml. This applied to 7
patients (1.1%). All patients received at least one periph-
eral venous access for administering contrast medium or
fluids and medication in case of complications. For plan-
ning purposes, a helical chest CT scan (General Electric
LightSpeed 16, Milwaukee, USA) without intravenous
contrast administration was performed for every patient
in 2.5 mm slice thickness, the results of which were
used to make the decision to perform the biopsy. After
a positive decision (610 patients; 98.9% of all patients
presented for biopsy), we attempted to find a comforta-
ble supine or prone position for the patient. After posi-
tioning, which was made on the basis of a planning CT
scan, one or two radiopaque bars were taped onto the
patient’s skin as markers. For the subsequent exact plan-
ning of needle pathway an in-plane technique was used
and the lesion was scanned once again. These images
were searched for a possible needle trajectory that
avoided visible bronchi and larger vessels. If a suitable
trajectory was not found, the gantry was tilted cranial or
caudal as it seemed best for removing the structures to
be protected from the biopsy plane, and a new CT scan
was made. When a possible biopsy pathway was finally
found, at least one other planning CT scan was super-
imposed on the region in question (helical mode, 2.5
mm slice thickness, fixed tube current of 100 mA) after
automatic intravenous injection (Missouri™, Ulrich
Medical, Ulm, Germany) of 50 ml Iopamidol 370
(Bracco S.p.A., Milan, Italy) with a flow rate of 2 ml/s
for visualizing vital segments of the tumor and to rule
out vascular malformations. In the selected slice, the
distance between the taped-on marker and the planned
needle insertion point was then measured. With the
help of the laser indicating the position of the table, this
distance was measured on the patients skin using a
ruler. This allowed the planned needle insertion point to
be marked on the skin. Iodine was applied, the region
was covered with sterile drapes, and 2 ml of prilocaine
1% (Xylonest™,A s t r a Z e n e c a ,V i e n n a ,A u s t r i a )w e r e
applied.
The SmartStep technique
The biopsy was conducted using the SmartStep™ tech-
nique (General Electric, Milwaukee, WI, USA). This
makes it possible for the examiner to operate the CT in
the examination room with a foot switch. When this
switch is activated, three axial slices are displayed on a
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1.25, 2.5, or 5 mm can be selected and overlap of 0.625,
1.25, 2.5, or 5 mm can also be selected. Using a manual
switch covered with a sterile film, the examiner can pull
the patient on the CT table out of the gantry or auto-
matically move him back to his last position. The exam-
iner can freely page through the planning sequence,
which can be displayed on the room monitor in parallel.
The planning drawing can be displayed and it is possible
to window the images. In comparison with fluoroscopy,
the advantages of this technique are superior image
quality and a lower dose for patient and examiner, but
the disadvantage is the delay of up to one second in dis-
playing the images.
Conducting the biopsies
Using this technique, the coaxial needle (17G, Bard Per-
ipheral Vascular Inc., Tempe, AZ, USA) was usually
inserted to the desired position during expiration. Pro-
ceeding as described by Lucidarme et al. [1], the man-
drel of the coaxial needle was then removed. The
cannula was immediately closed airtight with a cap (Fre-
senius Kabi AG, Bad Homburg, Germany) before
another control image was made without the mandrel. If
the needle was positioned correctly, an initial specimen
was taken using an 18G cutting system. The cap was
immediately replaced on the coaxial needle and the
position was checked. If the needle was not yet in the
correct position or if the position had changed, a correc-
tion was made. In this way, it was attempted to obtain
at least 3 contiguous tissue cylinders. When sufficient
material had been removed, 1 ml of fibrin glue was
injected per cm of needle track through aerated lung tis-
sue while withdrawing, as described by Petsas et al.
[20,21] in 1995.
Immediately after removing the needle and applying a
sterile adhesive dressing, a control CT scan was made of
t h ee n t i r et h o r a xt od e t e c ti n t r a v a s c u l a ra i rw i t ht u b e
voltage of usually 120 KV and tube currency of 100 mA
(0.6 seconds rotation time, 2.5 mm collimation, standard
and lung algorithm), and archived in the PACS-system.
Depending on the patient’s constitution, these para-
meters were occasionally adjusted if the same image
quality could be achieved in slender patients at a lower
dose or if a higher dose was required for very obese
patients. Two to three hours of bed rest, fasting, and
observation were ordered for the patient until a low-
dose follow-up CT was made to detect late occurrence
of pneumothorax, pleural effusion or parenchymal
hemorrhage.
Special features of the biopsies
If aerated tissue was traversed, fibrin glue (Tisseel™,
Baxter Healthcare, Deerfield, IL, USA) was subsequently
applied to seal the injection channel, as recommended
by Petsas et al. [20,21]. For 43 patients (7%), transpul-
monary biopsies of the mediastinum were made, mainly
of lymph node stations 7 and 10 [22]. Core tissue biopsy
needles with a diameter of 17/18G were used together
with coaxial biopsy needles with a diameter of 17G
(Bard Peripheral Vascular Inc., Tempe, AZ, USA) in 502
cases (82.1%), always in conjunction with a Magnum™
core needle biopsy system (Bard Peripheral Vascular
Inc., Tempe, AZ, USA). Indications for endotracheal
anesthesia were small tumor size, immediate proximity
of the tumor to large vessels of the hilum, mediastinum,
or heart, and patient’s request or inability to understand
the national language. Some patients were already intu-
bated when they came from an intensive care ward. All
children were biopsied under endotracheal anesthesia.
The PCNBs were performed by four experienced, board-
certified radiologists.
Conducting the examinations and definitions
The examinations were evaluated retrospectively by two
observers in consensus on a PACS evaluation worksta-
tion (Picture Acquisition and Communication Software;
Tiani 3D PACS, Version 3.3.16, Agfa-Gevaert N. V.,
Mortsel, Belgium) designed for the purpose. Hypodense
areas located in the left atrium, left ventricle, or in pul-
monary veins which appeared during the biopsy, were
visible in at least two consecutive slices, and had Houns-
field levels < -200 HU were considered to be intravascu-
lar air. The assessment was verified by a third, very
experienced observer (BG). For the diagnosis of intravas-
cular air, all available image data were used; this
included images during the SmartStep procedure as well
as subsequent thin collimated control CT scans together
with coronal, and sagittal reconstructions. All images
had been processed in a standard and a lung reconstruc-
tion kernel, and all data sets were stored in the PACS
system, as well as the original 0.625 mm collimated
images. The mean density within the intravascular gas
was -383.5 ± 266.2 Hounsfield units. Complications
were classified according to the Society of Interventional
Radiology Clinical Practice Guidelines of 2003 [23].
Parameters measured
The parameters explained below were considered as risk
factors for the occurrence of an embolism. Under the
hypothesis that the probability of injuring a vessel would
increase the more biopsies were taken, the number of
biopsies taken was recorded. The penetration depth of
the cutting needle in the lesion and thus the length of
the biopsy cylinder could be varied. It was usually 15 or
22 mm, but for smaller lesions shorter cutting lengths
were also used. This parameter was designated the
penetration depth of the biopsy needle (mm). The
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the skin with a local anesthetic and removal of the coax-
ial needle after completing the biopsy in minutes. Size
and volume of the tumor were determined at a 3D post-
processing workstation (Advantage Windows Version
4.4, General Electric, Milwaukee, WI, USA), and indi-
cated in millimeters or milliliters. Vasculitis, for example
Wegener’s granulomatosis, and mycosis were considered
potential risk factors, as was the presence of necrosis as
a categorical variable. Traversing aerated healthy lung
tissue versus the direct biopsy of pleural-based lesions
without traversing aerated tissue was also considered a
risk factor in the sense of a categorical variable. Other
categorical variables were prone or supine position of
the patient and the differentiation between endotracheal
anesthesia or local anesthesia, as well as the complete-
ness of the fibrin line through the lung after removal of
the needle. The distance of the tumor from the apex of
the lung in relation to the total length of the lung in the
body’s longitudinal axis was considered, as was the dis-
tance of the tumor ventral from the dorsal border of the
lung in relation to the total width in the anterior-poster-
ior dimension, and the distance of the tumor mediast-
inal to the lateral border of the lung in relation to the
total area in the coronal dimension. These were relative
measures for the location of the tumor in the space of
the lung, in the sense of a three-dimensional coordinates
system. They were indicated in percentages. For deter-
mining these data, strictly transverse, sagittal, or coronal
oriented, 3D, minimum-intensity projection reconstruc-
tions were made on the aforementioned post-processing
workstation. The position of the mid-point of the tumor
with respect to the mid-point of the left atrium was
taken into consideration. To do this, the distance of the
plane parallel to the table top through the center of the
tumor from the plane parallel to the table top through
the center of the atrium was indicated in millimeters,
with a positive algebraic sign if the tumor was closer to
the table top than the atrium and a negative algebraic
sign if the tumor was higher than the atrium above the
table top. In an analogous manner, the vertical distance
between the center of the tumor and the tabletop was
determined in centimeters. The subjective extent of
patient movement on a scale of one to four was
recorded. One meant that the patient was very still and
did not move; four meant that the patient had moved a
great deal during the examination, e.g. by placing his
arm, which was positioned over the head, next to his
b o d yo rv i c ev e r s ao rb yc h a n g i n gh i sp o s i t i o n .T h e
pleura-tumor distance in centimeters, the emphysema in
the needle trajectory zone through the lung indicated in
Hounsfield units, the partial thromboplastin time (in
seconds), prothrombin time (%), platelet count, age in
years, and sex were taken into consideration. The
greatest diameter of any bleeding into the lung was
measured in millimeters and considered as a parameter.
The smallest angle between the needle and the surface
of the tumor at the point the needle entered the tumor
was considered as “needle angle to the tumor surface”.
The slice thickness of the axial images in the SmartStep
mode during the biopsy was also recorded. The para-
meter “coughing” was recorded only rarely; we therefore
did not include it in the evaluation.
Measures in the event an SAE occurred
If an air embolism was detected during or directly after
the procedure, immediate measures were initiated. All
four cases (4/23) occurred in a prone position. The head
was lowered in the Trendelenburg position to prevent a
cerebral infarction and the biopsy was terminated. Pure
oxygen was administered and intravenous anticoagula-
tion with unfractionated heparin was initiated [24,25].
The position was maintained until all the air was physi-
cally reabsorbed. Immediately after this, a neurological
examination was ordered. The remaining cases were not
detected until the neurological symptoms occurred after
the biopsy (n = 2; 2/23), or until the retrospective eva-
luation of the images.
Statistics
Descriptive statistics were made using the Excel pro-
gram (Microsoft, Seattle; WA, USA). All analyses were
made for each biopsy. For example, if a re-biopsy was
needed for a patient, the re-biopsy was counted as a
new biopsy. Using distribution analyses with the aid of
D’Agostino-Pearson tests, group comparisons were
made using the Mann Whitney U test or Student’s t-test
[26], where appropriate. Theu n i v a r i a t ec o m p a r i s o no f
categorical parameters was always carried out using
Fisher’s exact test, which was calculated using GraphPad
Prism, version 5.00 (Graph Pad Software, San Diego,
CA, USA). Logistic regression models were then fitted
using standard decision criteria and taking all possibly
significant parameters determined by univariate methods
into consideration and further selection of parameters
was made on the basis of the regression models. Finally,
in a forward stepwise selection procedure under consid-
eration of the selected parameters, logistic regression
models were fitted to the target variables for “intravas-
cular air”. The program SPSS 15 (SPSS Inc., IBM, Chi-
c a g o ,I L ,U S A )w a su s e df o rt h i s .P<0 . 0 5w a s
considered statistically significant.
Results
Assigning patients to the two groups
For 23 patients, 8 women and 15 men with a mean age
of 56.5 ± 18.1 years, an SAE was verified during or after
the biopsy. This is equivalent to 3.8% of all patients. No
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men with a mean age of 63.7 ± 13.4 years, correspond-
ing to 96.2% of all patients.
Complications
Hemorrhage was verified by CT scan in 400 patients
(65.6%). Of these, 397 cases (99.3%) required no therapy
(minor complication A), and 3 required nominal therapy
consisting of bronchoscopic suctioning (minor compli-
cation B). In one patient, the bleeding had to be treated
by microcoil embolization of the intercostal artery. Her
hospital stay was extended by more than 48 hours
(major complication D).
Pneumothorax developed in 94 patients (15.4%); ten
patients (1.6%) had to be treated with a chest tube and
84 patients (89.6%) were observed only. This was classi-
fied as minor complication A for 83 patients, as minor
complication B for one patient requiring nominal ther-
apy, and major complication D for 10 patients requiring
prolonged hospitalization > 48 hours.
Complications due to intravascular air
While no symptoms occurred in 20 of the 23 patients
with SAE, three patients showed symptoms. One male
patient developed a transient bilateral amaurosis (major
complication D, prolonged hospitalization > 48 hours),
one male patient had transient hemiplegia that regressed
completely (major complication D, prolonged hospitali-
zation > 48 hours), and one female patient suffered a
fatal coronary infarction from an SAE (major complica-
tion F, death; Figure 1). The mortality from SAE was
thus 1/610 (0.16%), morbidity was 2/610 (0.3%).
Detection of intravascular air
In four patients, the embolism was detected during or
directly after the examination on the basis of the CT
scans; in two patients, shortly afterward due to the
symptoms of amaurosis and cerebral infarction. The
other 17 cases were detected retrospectively when evalu-
ating the images in the PACS for this study. Other
examples of SAE’s are shown in Figure 2 and 3.
Univariate analysis of the risk factors
In the univariate analyses of categorical variables, prone
position of the patient, and location of the lesion in the
lower lobe were risk factors for an SAE (p < 0.05 each,
Table 1). There was also a tendency seen for the factor
endotracheal anesthesia (p < 0.1, Table 1). In the uni-
variate analyses of continuous variables, caudal position
of the lesion, level of the lesion above that of the left
atrium respective to the patient’s position, large number
of biopsies, and small CT-slice thickness during the
biopsy, were risk factors for an SAE (p < 0.05 each,
Table 2). An intravascular position of the tip of the nee-
dle was never observed.
Multivariate analysis of the risk factors
The independent risk factors for the occurrence of an
SAE, determined using standard selection criteria in the
order of significance, are shown in Table 3. If less
restrictive selection criteria were used for including a
variable in the model (probability for stepwise entry 0.1
and removal 0.2), the factors needle path through venti-
lated lung and acute angle of the needle to the surface
of the tumor also occur in the models (Table 4)
Figure 1 a and b: Transversal CT-slice, showing SAE in the coronary arteries, the aorta, the left atrium and ventricle (a). The lesion was
located in the left upper lobe (b), at the time of biopsy approximately 8 cm above the level of the left atrium. 49 y/o patient after lung
transplantation, suffering from pulmonary aspergillosis. She died due to coronary ischemia.
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This study is the first one to identify risk factors for the
occurrence of an SAE that depend on the biopsy techni-
que. Risk factors include needle depth in the tumor,
endotracheal anesthesia, level of the tumor above the
left atrium, and prone positi o n .I nt h eu n i v a r i a t ea n a -
lyses, prone position of the patient, location of the lesion
in the lower lobe, basal location of the tumor, level of
the lesion above the level of the left atrium, large num-
ber of biopsies were significant. If the presence of intra-
vascular air is investigated, the incidence is clearly
higher than previously indicated. However, with a radi-
ological incidence of 3.8%, an air embolism is still con-
sidered rare, but its consequences are potentially fatal.
In our study, the mortality of 0.16% was attributed to a
coronary infarction from an air embolism. However, the
morbidity caused by the SAE of one case each of
transient amaurosis and transient hemiplegia is compar-
able with the results of other studies [2-4,4,6-8].
The fact that only 26.1% of the air embolisms were
detected during or immediately after the biopsy should
draw the conclusion that the radiologist should be more
aware of the incidence of SAE during and directly after
biopsy and that a meticulous search for intravascular air in
the left atrium or left ventricle should be prompted by the
radiologist before terminating the procedure. This could
prevent the protean manifestations of SAE from the left
atrium or left ventricle due to the fact that immediate
measures could be initiated while the patient is still on the
examination table, for example Trendelenburg positioning,
administering pure oxygen and initiating unfractionated
heparin i.v. therapy. Probably, these measures might have
prevented the neurological sequelae in two study patients
with amaurosis and cerebral infarction.
Figure 2 a and b: Transversal CT-slice of a 29 y/o patient during the biopsy of a tumor located in the right hilum of the lung (a). The
CT-Scan after biopsy showed a SAE in the apex of the left ventricle (b), which was treated immediately. There were no clinical sequelae.
Figure 3 a and b: Transversal CT-slice of a 48 y/o patient during the biopsy of a small nodule located in the left lower lobe (a).T h e
CT-Scan after biopsy showed a SAE in the left atrium, the aorta, and intercostal arteries (b). The patient suffered from a transient amaurosis.
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images, the radiological incidence of air embolism was
3.8%, as mentioned above, much higher than the clini-
cally apparent incidence, which was consistent with that
indicated in other studies [2-8]. The fact, that many of
the SAE’sa r ev i s i b l eo n l yb yr a d i o l o g yi na ne s p e c i a l l y
designed protocol must be taken into consideration
when the high radiological incidence of air embolisms
found here is compared with the clinical data indicated
in literature.
Our study represents the first study with a systematic
retrospective search for intravascular air embolisms in a
study population and with the deduction of risk factors.
The knowledge of risk factors allows implementation of
adequate measures before the biopsy procedure and
may prevent potentially harmful SAE in the future. A
good example represents the female patient with SAE to
the left coronary artery and subsequent cardiac arrest
and death. Three risk factors were present during the
biopsy procedure, i.e. prone position, location of the
lesion above the level of the left atrium and general
anesthesia, but these were not known until this study.
Unfortunately, we could not influence any of these fac-
tors retrospectively; that is the nature of the retrospec-
tive design of the study.
In principle, all the factors named can be easily influ-
enced by the radiologist performing the procedure, how-
ever, before drawing any consequences from the study,
its limitations should be pointed out. According to the
USPSTF classification, the level of evidence is II-2. This
is a retrospective observational study, which means that
even if it is conducted accurately, due to the non-con-
sideration of factors that, for example, were not docu-
mented by the examiner, uncontrolled and
uncontrollable errors can arise. Although statistical
analyses of the 23 cases with SAE were possible for the
first time, it is conceivable that some factors could have
been mathematically eliminated from the regression
models due to the small size of the patient group with
the event. Certain factors of influence such as the biopsy
of cavitary or vasculitic lesions [17], whose influence
definitely seems plausible, could not even reasonably be
accounted for in the models due to their sparsity. On
the other hand, it is certainly conceivable that some fac-
tors we named might turn out to be non-existent or
coincidental in a prospective verification. As can be seen
in Table 2 the standard deviation of the factor depth of
the needle in the tumor is especially large in the group
of patients with an air embolism, and the needle depth
in the tumor covered by the standard deviation is largely
consistent with the area covered by the standard devia-
tion of the other group - and yet the factor is retained
in the multivariate analyses. We have no explanation for
this, but we report this result and recommend that it
should be confirmed or rejected on the basis of other
studies. Another weakness is that no systematic clinical
follow-up examinations were made. All patients were
s e e na g a i nb yt h er a d i o l o g i s ti naf i n a lc o n s u l t a t i o nt w o
to four hours after the biopsy for a control CT scan, but
there are no systematic records of this talk. Unfortu-
nately, there is no record of the probably very important
factor “coughing” [27]. Finally, it must be stated that not
CT, but transesophageal and probably transcutaneous
echocardiography must be considered the gold standard
diagnostic measure. Using transesophageal techniques,
even the smallest gas bubbles can be detected [15,28,29]
and relatively small amounts of air can be detected even
transcutaneously [15]. As we did not use these methods,
the reported incidence might still underestimate the
true occurrence, although storing the thin collimated
Table 1 Univariate analysis of categorical data using Fisher’s exact test.
Patients with air embolism Patients without air embolism
Factor
present
Factor not
present
% Factor
present
Factor not
present
% Significance
FET
Prone position 19 4 82.6 269 318 45.8 0.0005 (s)
Lobar location: Upper lobe, middle lobe or lingular
segments
10 13 43.5 391 196 66.6 0.0261 (s)
Bleeding of any extent visible 18 5 78.3 382 205 65.01 0.053 (ns)
Intubation anesthesia 17 6 74 308 279 52.5 0.0543 (ns)
Mycosis present 2 21 8.7 16 571 2.7 0.1443 (ns)
Necrosis present within the lesion 6 17 26.0 88 499 15 0.1467 (ns)
Needle path through ventilated lung 20 3 87 452 135 77 0.3203 (ns)
Hemoptysis 1 22 4.3 11 576 1.8 0.3722 (ns)
Pneumothorax 5 18 21.8 89 498 15.1 0.3784 (ns)
Gender (female) 8 15 34.8 244 343 41.6 0.6669 (ns)
Fibrin glue line complete 17 6 74 404 183 69 0.8185 (ns)
Vasculitis present 0 23 0 6 581 1.02 1 (ns)
Abbreviations: FET-Fisher’s exact test; ns-not significant; s-significant
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dure and then having them evaluated retrospectively by
three different persons allows us to presume high sensi-
tivity for detecting intravascular air. Finally, we have to
consider that among our patients, only 3 showed
clinically apparent complications of SAE, too few for
further analysis.
The result that endotracheal anesthesia is a risk factor
for the occurrence of air embolisms is not surprising, as
positive-pressure ventilation has already been suspected
Table 2 Univariate analysis of continuous data using the Mann-Whitney test.
Patients with air
embolism
Patients without air
embolism
Mean Median SD Mean Median SD Unit of
measurement
Significance
WMT
Level of the lesion above the left atrium 57 63,3 33.2 29.1 33.7 38.9 mm 0.0008 (s)
Needle angle to the tumor surface 65.7 68.4 17.2 72.1 75.1 15.7 Angular
degree
0.0638 (ns)
Collimation during the biopsy (smart step) 2.2 2.5 0.8 2.4 2.5 0.5 mm 0.0318 (s)
Number of biopsies 8.9 8 3.0 7.7 7 3.3 number 0.0356 (s)
Absolute Distance from the apex of the lung to the lesion 137.4 151 65.5 110.9 104.3 75.2 mm 0.0397 (s)
Number of specimens 6.8 7 2.1 6.1 6 2.7 number 0.0569 (ns)
Relative distance from the apex of the lung to the lesion 50.6 58.8 22.6 42.6 39.1 24.7 % 0.0606 (ns)
PT 108.1 109 13.5 102.9 103 13.0 % 0.1136 (ns)
Duration of biopsy 49.3 29.9 60.0 25.9 22 14.5 minutes 0.2461 (ns)
Patients age 56.4 62.2 18.0 61.8 63.7 13.4 years 0.2521 (ns)
Rectangular distance from the plane of the most posterior point
of the lung to the tumor (absolute)
71.6 62.6 41.0 79.5 74.5 41.4 mm 02854 (ns)
Distance between pleura and tumor in the needle trajectory 19.8 20.5 13.2 24.5 21.2 19.4 mm 0.3322 (ns)
Vertical distance between the lesion and the tabletop 156.5 161 45.2 150.4 145 60.2 mm 03499 (ns)
Rectangular distance from the plane of the most posterior point
of the lung to the tumor (relative)
37.5 34.2 23.0 40.6 38.2 22.0 % 0.3599 (ns)
Platelet count 229.3 234 86.1 254.2 243 88.9 Number/ml 0.4030 (ns)
Needle deepness in tumor 10.5 7.1 12.2 7.7 5.3 9.1 mm 0.4589 (ns)
Degree of movement of the patients 1.4 1 0.6 1.6 1 0.8 Ordinal scale
(1-4)
0.4849 (ns)
FEV1 2.4 2.4 0.8 2.3 2.1 0.9 liter 0.4974 (ns)
Diameter (WHO) 22.7 18.1 13.1 22.5 17 16.2 mm 0.5597 (ns)
Density of the lung -848.1 -859 43.9 -843.2 -849 50.2 Hounsfield
units
0.5602 (ns)
Axial diameter of the lesion (RECIST) 32.7 28 23.2 30.0 22.4 23 mm 0.5820 (ns)
Volume of the lesion 30.6 6.3 50.9 30.9 5.8 81.9 ml 0.6188 (ns)
PTT 29.7 28.5 4.6 29.9 29 4.3 seconds 0.6736 (ns)
Rectangular distance from the plane of the most lateral point of
the lung to the tumor (relative)
53.1 50.6 17.7 52.1 52.0 19.5 % 0.8185 (ns)
Diameter of a visible bleeding in lung (RECIST) 17.5 15.5 13.1 19.4 16.4 20.1 mm 0.8908 (ns)
Rectangular distance from the plane of the most lateral point of
the lung to the tumor (absolute)
74,9 72 25.9 73.6 73.8 28.1 mm 0.9235 (ns)
Biopsy length 16.3 15 3.4 16.7 15 3.3 mm 0.9266 (ns)
Abbreviations: FEV1-Forced Expiratory Volume in 1 second; ml-Milliliter; mm-Millimeter; ns-not significant; PT-Prothrombine-Time; PTT-Partial Thromboplasine
time; s-significant; WMT-Whitney-Mann Test
Table 3 Logistic regression model using standard selection criteria with the target parameter “SAE”.
Model Selection
criteria
Wald p Assessment
Needle penetration depth in the tumor (Needle tip not in the tumor
is risk factor)
1 Standard 6.9 0.009 Most important independent risk
factor
Intubation anesthesia (Anesthesia is risk factor) 1 Standard 5.7 0.017 Independent risk factor
Height above the level of the left atrium (Height is risk factor) 1 Standard 5.2 0.023 Independent risk factor
Prone or supine position (prone position is risk factor) 1 Standard 4.3 0.038 Independent risk factor
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Page 8 of 12as such in literature [17,30,31]. The higher the intra-
alveolar or intra-bronchial pressure, the greater the dan-
ger of air passing from the aerated areas of the lungs to
the vascular system is [15]. Though we have no exact
information regarding the ventilation pressure used on
our patients, it is advisable to keep it as low as possible.
The high percentage of biopsies conducted under endo-
tracheal anesthesia in comparison with literature can be
attributed to the large number of complex procedures,
such as biopsies of lesions located in close proximity to
the heart and tumors that were smaller than 1 cm, and
even smaller than 0.8 cm. Additionally, many lesions in
lymph node stations 10, 11, 12, 13, and 14 were biop-
sied, positions in which even the smallest deviations
from the plan could lead to severe complications from
bleeding. Children, mentally impaired patients, on
patient’s request or inability to understand the national
language were not biopsied under local anesthesia for
obvious reasons, nor were already intubated patients
from the intensive care ward. In some cases, in the
initial medical discussion for a biopsy, patients are
advised by their pulmonologist to have “short-acting
anesthesia”. We have discontinued this liberal handling
of endotracheal anesthesia in view of the result that it
could be an independent and very plausible risk factor
for the occurrence of an SAE. We now advise patients
against anesthesia whenever possible and offer analgesic
sedation. If endotracheal anesthesia appears to be neces-
sary, the needle is now removed during breath-hold in
expiration position after disconnecting the ventilator.
The risk of air inflow to a vein depending on the posi-
tioning of the patient is also known from neurosurgery
[12]. A sitting position with the head as the highest
point of the body is considered especially risky [15]. The
frequency of occurrences of intravascular air during
PCNB from a tumor located above the level of the left
atrium can be explained similarly - the higher the lesion
above the left atrium, the lower the pulmonary venous
pressure and the greater the danger of air inflow if a
vascular wall is damaged. This also explains the risk of
the prone position, as most lesions in the lower lobe are
biopsied in this position, which are then located far
above the level of the atrium. As a consequence, it must
be concluded that positioning a lesion above the level of
the left atrium and also prone position are to be
avoided. Accepting the longer parenchymal path
required for the biopsy of dorsal tumors in supine posi-
tion might thus be safer with respect to the probability
of an embolism.
The most important independent risk factor, namely
needle penetration depth in the tumor, is very plausible.
The deeper the tip of the needle in the tumor was, the
lower the risk of an air embolism because no aerated
parenchyma was located there and therefore no alveo-
lar-venous or bronchial-venous fistula could be formed.
Conversely, when the tip of the needle was outside of
the tumor and the biopsy was made from the aerated
tissue into the tumor, this was the greatest risk factor.
From this it can be concluded that the tip of the needle
should be placed within the tumor whenever possible
and the aerated lung tissue in front of the tumor should
not be included in the biopsy.
T h ef a c tt h a tb o t hp r o n ep o s i t i o na n dl e v e lo ft h e
tumor above the left atrium are retained in the model
independently of one another must be observed more
closely. Prone position does not necessarily mean that
the tumor was located above the level of the left atrium,
and supine position does not necessarily mean that the
lesion was located below the level of the atrium, making
it plausible that the factors are independent of each
other. However, if the factor prone position is omitted
from the models, the factor level of the tumor above the
left atrium became more important and vice versa. This
leads us to conclude that that the factors are not totally
independent of each other. Moreover, it is possible that
prone position as compared with supine position results
in a reduction in compliance of the thorax that changes
intrathoracic pressure ratios, so that prone position itself
could increase the risk. However, such considerations
are highly speculative and are not further supported by
our results.
It is theoretically conceivable that by applying fibrin
glue during needle removal to prevent pneumothorax,
some air could be injected. Arguments against this
Table 4 Logistic regression model using explorative selection criteria with the target parameter “SAE”.
Model Selection
criteria
Wald p Assessment
Needle penetration depth in the tumor (Needle tip not in the tumor
is risk factor)
2 Explorative 9.1 0.002 Most important independent risk
factor
Intubation anesthesia (Anesthesia is risk factor) 2 Explorative 6.8 0.009 Independent risk factor
Height above the level of the left atrium (Height is risk factor) 2 Explorative 6.0 0.014 Independent risk factor
Needle angle to the tumor surface (More acute angle may be risk
factor)
2 Explorative 4.6 0.032 Independent risk factor
Prone or supine position (prone position is risk factor) 2 Explorative 3.3 0.067 Independent risk factor
Needle path through ventilated lung 2 Explorative 2.9 0.085 Independent risk factor
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Page 9 of 12mechanism are the fact that lack of air was always
ensured before the injection and that the injection was
administered only while withdrawing the needle to avoid
applying a large amount of glue in one place. Since the
fibrin glue was not omitted for any patient, the injection
with fibrin glue could not be tested in this study with
respect to a possible inherent risk. We do not believe
that the fibrin glue could have had a significant role
because the amount injected was always proportional to
the length of the needle track through aerated lung tis-
sue and there was thus covariance with a factor that
played no role in the multivariate models. A prospective
study of the risk to patients of administering fibrin glue,
e.g. by omitting the fibrin glue in randomly selected
patients with the advantages reported by Petsas et al.
[20,21] in mind appears to be ethically problematic to
say the least, and would require a protocol with interim
analyses so that the study could be discontinued in the
event an increased risk of pneumothorax became
apparent.
The use of a coaxial system could be in itself a concei-
vable reason for the occurrence of an air embolism. The
perfect workmanship of these products and the precise
fit of the diameter of the cutting needle system to the
inner diameter of the coaxial system could lead to the
result that when inserting the cutting needle system into
the coaxial needle, air is pressed through the coaxial
needle into the patient’s body. However, in a 10-cm
long system, this would be maximum 0.011 cm
3 and in
a 15-cm long system, maximum 0.017 cm
3 - amounts
that could not be detected by CT scan even with a slice
thickness of 0,625 mm. Furthermore, the number of
biopsies, which is a gauge for the procedure of inserting
the cutting needle into the coaxial needle, was not a risk
factor for SAE. We therefore do not consider the use of
a coaxial system to cause air embolisms in lung biopsies.
Subordinate, but conspicuous variables in the univari-
ate analyses that could potentially influence the occur-
rence of an SAE were the number of biopsies taken and
the penetration depth of the cutting needle. This
appears to be immediately explainable, as an additional
injury is caused with every biopsy or every specimen
removed, which can ultimately lead to perforating a pul-
monary vein. Increasing the penetration depth of the
cutting needle system increases the length of the inci-
sion to extract a longer biopsy cylinder and a corre-
spondingly longer section of tissue is injured.
If the tumor is not penetrated in the precise center,
which is sometimes necessary because the center of the
tumor is necrotic and would not yield any suitable spe-
cimens, the vital borders of the tumor are used instead.
If the needle is then inserted tangentially into the tumor
margin, it is conceivable that due to even a slight devia-
tion, normal lung tissue and the junction from the
tumor to the lung would be biopsied. This junction
zone contains the vessels that the tumor displaces by its
growth, so that an acute angle of the needle to the sur-
face of the tumor also appears to be a plausible risk fac-
tor for an SAE, because the closer to the tumor margin
the needle is inserted, the more acute this angle is. The
position of a lesion near the base of the lung was also a
subordinate risk factor. This can be explained by the
fact that lung excursions are more pronounced in the
basal region than in the apical region, which leads to a
greater probability that vessels can be injured by the
associated movement.
Since a fine needle biopsy (FNB) was not performed
for any of the patients in our study, no statement with
respect to the safety of PCNB in comparison to FNB
can be made.
Due to the correlations between the position of the
lesion in relation to the left atrium, needle angle with
respect to the surface of the lesion, frequency of biopsy
samples, and penetration depth with the occurrence of
air embolisms, we consider the mechanical development
of an alveolar-venous fistula to be the most likely reason
for SAE [15]. In view of the infrequency of hemoptysis
in both groups (Table 1), bronchial-venous fistulas
[14,15] appear to be unlikely, as does the pulmonary-
arterial injection of air, because we did not find bleeding
from the needle track in any patient nor was an intra-
vascular position of a needle tip verified. However it is
conceivable that air can enter a pulmonary vein, perhaps
invisible due to its small size [11,13], from the tip of the
needle or via a temporary alveolar-venous fistula con-
nected with the lumen of the needle. For this reason,
t h en e e d l em u s ta l w a y sb ec l o s e da i r t i g h ta n ds h o u l d
not be left in situ unclosed any longer than absolutely
necessary.
One further limitation of the study that should be
mentioned is that the results are transferrable only to a
limited extent to other centers that use endotracheal
anesthesia less often. But because the risk factors level
of the lesion above the atrium, positioning the patient in
prone or supine position, and needle penetration depth
in the tumor were factors independent of this, its signifi-
cance might even be underestimated in this study out of
statistical considerations. Any upward correction of the
extent of the influence of these factors must be the sub-
ject of new studies, perhaps conducted in parallel in
other centers. Conducting a prospective study does not
seem to be ethically justifiable in light of our results.
Only animal studies with specific individual technical
research questions on the topic might possibly be
conducted.
In summary, we can state that needle penetration
depth in the tumor, endotracheal anesthesia, level of the
lesion above the left atrium, and prone position are
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embolism. Subordinate risk factors could include an
acute angle of the needle to the tumor surface, fre-
quency of biopsy samples, penetration depth of the cut-
ting needle, and basal position of the lesion. The
radiological incidence of an air embolism is 3.8%, clearly
higher than previously estimated, while the incidence of
clinically apparent air embolisms was consistent with
that reported by other studies. About 15% of patients
with confirmed intra-arterial air develop severe and
potentially fatal consequences. To prevent air embo-
lisms, endotracheal anesthesia should be avoided when-
ever possible. We recommend positioning the lesion to
be biopsied below the level of the left atrium, and posi-
tioning the patient in supine position. The tip of the
biopsy needle should be within the lesion during the
biopsy procedure and including aerated lung tissue in
the biopsy should be avoided.
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